Anzeige
Mehr »
Login
Montag, 01.06.2020 Börsentäglich über 12.000 News von 628 internationalen Medien
Silber-Aktien im Rausch! Diese Silber-Granate steht vor massiver Neubewertung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Endpoints News

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
13.05.Amgen researchers confirm the lackluster data on the KRAS G12C drug AMG 510 reported at ESMO - but they still have a long way to go exploring options
13.05.Sanofi walks back Paul Hudson's promise of early vaccine access for the US - sort of
13.05.Merck pours $400M into flea drugs for Fido; Avrobio shows durability; Rhythm gets priority review
13.05.One year on, Capricor's stem cell therapy appears to help DMD patients in small study, but investors balk at the data
13.05.Boehringer Ingelheim sharpens retinal strategy, scooping up dry AMD drug from a Swiss team behind Novartis' Beovu
13.05.Sanofi flashes more PhIII data on new multiple myeloma drug, setting up battle with Darzalex
13.05.UPDATED: FDA spurns an application from Bristol Myers and bluebird for ide-cel, threatening to kill a $9 CVR
13.05.(Another) activist attack on Alexion, as Paul Singer-founded hedge fund calls for biotech to sell itself
13.05.The new CEO at troubled AMAG begins his battle against an array of threats by axing staff and slashing costs
13.05.Covid-19 roundup: Gilead selects 5 manufacturing partners for remdesivir; CanSino outlines PhI/II study in Canada
13.05.Precision therapy approach secures small biotech $42M haul to combat disease that inspired the Ice Bucket Challenge
13.05.FDA issues two guidances to accelerate Covid-19 treatments
12.05.Chinese biotech aims $232M in IPO cash to push next-gen prostate cancer drug; Immunomedics raises nearly a half-billion off approval
12.05.Positive pivotal cell graft data bring Novartis-backed Boston biotech step closer to finish line
12.05.With money flowing, Pliant Therapeutics heads to public well
12.05.Merck doubles down on Skyhawk's tech to drug RNA, promising $600M per autoimmune, metabolic target
12.05.Vivek Ramaswamy's brother, Shankar, spins out on his own, launching audacious gene therapy play
12.05.Covid-19 roundup: Aimmune pauses launch of peanut allergy therapy; India kicks off first coronavirus trial - its drug of choice is Fujifilm's favipiravir
12.05.Ex-DARPA chief Regina Dugan, Illumina founder Jay Flatley join Wellcome Trust fund to tackle global health's Sputnik moment
11.05.Genfit's NASH drug fails a closely-watched PhIII showdown, adding one more setback to a plagued field
11.05.CEPI bets $384M on Novavax's Covid-19 vaccine - covering R&D and manufacturing in the groundbreaking race to beat the pandemic
11.05.Merck to move global headquarters, returning to an old home
11.05.Fritz Gerber, who led Roche for 2 decades, dies; ADC Therapeutics tries again for an IPO, sets terms
11.05.'We're good to go': MyoKardia clinches crucial PhIII win, boosting genetic approach to cardio R&D
11.05.Small biotech Oyster Point sets up pitch to disrupt dry eye market with nasal spray